| CTRI Number |
CTRI/2025/07/091961 [Registered on: 29/07/2025] Trial Registered Prospectively |
| Last Modified On: |
29/07/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
Levels of VEGFR2, Dab-2 and FOXM1 in periodontal disease and diabetes |
|
Scientific Title of Study
|
Estimation of Vascular endothelial growth factor receptor-2 (VEGFR2), Disabled Homolog-2 (Dab-2) protein and Forkhead Box M1 (FOXM1) levels in saliva and serum in generalized periodontitis patients with and without Type 2 Diabetes Mellitus (T2DM) |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Aparna Rajesh |
| Designation |
Post graduate |
| Affiliation |
The Oxford Dental College, Bangalore |
| Address |
Department of Periodontology, Room no.3, The Oxford Dental College,
10th milestone, Bommanahalli, Hosur Road, Bengaluru- 560068
Bangalore KARNATAKA 560068 India |
| Phone |
8660025773 |
| Fax |
|
| Email |
aparnatrajesh@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Ashish S Nichani |
| Designation |
Professor |
| Affiliation |
The Oxford Dental College |
| Address |
Department of Periodontology, Room no.3, The Oxford Dental College,
10th milestone, Bommanahalli, Hosur Road, Bengaluru- 560068
Bangalore KARNATAKA 560068 India |
| Phone |
9845252203 |
| Fax |
|
| Email |
nichaniashish@hotmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Ashish S Nichani |
| Designation |
Professor |
| Affiliation |
The Oxford Dental College |
| Address |
Department of Periodontology, Room no.3, The Oxford Dental College,
10th milestone, Bommanahalli, Hosur Road, Bengaluru- 560068
Bangalore KARNATAKA 560068 India |
| Phone |
9845252203 |
| Fax |
|
| Email |
nichaniashish@hotmail.com |
|
|
Source of Monetary or Material Support
|
| The Oxford Dental College, Department of Periodontology, Room no.3,
10th milestone, Bommanahalli, Hosur Road, Bengaluru- 560068 |
|
|
Primary Sponsor
|
| Name |
Dr Aparna Rajesh |
| Address |
Department of Periodontology, Room no.3, The Oxford Dental College,
10th milestone, Bommanahalli, Hosur Road, Bengaluru- 560068
Karnataka Bangalore KARNATAKA 560068 India |
| Type of Sponsor |
Other [Self funded] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Aparna Rajesh |
The Oxford Dental College, Bangalore |
Department of Periodontology, Room no.3, The Oxford Dental College,
10th milestone, Bommanahalli, Hosur Road, Bengaluru- 560068 Bangalore KARNATAKA |
8660025773
aparnatrajesh@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee The Oxford Dental College |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
35.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1. Patients who have not received any periodontal treatment in the previous six months.
2. Patients diagnosed with T2DM as per American Diabetes Association criteria (2019).
3. Patients with a diagnosis of generalized periodontitis as per World Workshop Classification criteria (2017). |
|
| ExclusionCriteria |
| Details |
1. Smokers and alcoholics.
2. Patients with systemic diseases like hypertension, cardiovascular diseases, rheumatoid
arthritis, tumors, autoimmune diseases and renal diseases.
3. Pregnant and lactating females.
4. Any other systemic disease which can alter the course of periodontal disease.
5. Patients on medications like anti-inflammatory drugs, antibiotics and anti-epileptic drugs in
the past 6 months.
6. Post-menopausal women. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate serum and salivary levels of Vascular endothelial growth factor receptor 2, Disabled homolog-2 protein and Forkhead Box M1 in periodontitis and T2DM patients at baseline |
Baseline |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To explore correlation of Vascular endothelial growth factor receptor 2 with Disabled homolog-2 protein & Forkhead Box M1 & clinical, biochemical & demographic parameters at baseline |
Baseline |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/10/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Periodontal disease is one of the major problems encountered in patients with Type 2 diabetes mellitus (T2DM) which in turn is an important and independent risk factor for the development of periodontitis. While periodontitis represents a distant source of low-grade systemic inflammation and impaired metabolic control, on the other hand, microangiopathy and an increased angiogenic response, typical of T2DM, are correlated to the progression of periodontitis. Angiogenesis is also thought to be an essential process in the development of both these chronic inflammatory diseases. Vascular endothelial growth factor (VEGF), a 45-kd homodimeric pro-inflammatory glycoprotein is a critical angiogenic factor that signals through VEGF receptors (VEGFRs). VEGF receptor 2 (VEGFR2) potentiates angiogenesis more potently than other VEGFRs. In diabetic conditions, there is a decrease in VEGF-induced phosphorylation of VEGFR2 and downstream signaling, leading to impaired angiogenesis. VEGF and VEGFR2 overexpression, as well as the great proliferation rate of endothelial cells observed in periodontitis suggest that angiogenesis in case of periodontal lesions is dependent on VEGF expression. Disabled Homolog 2 (Dab2) is a highly conserved adaptor protein widely expressed in various tissues and primarily functions as a cytosolic, clathrin and cargo binding adaptor protein, with a pivotal role in endocytosis. Dab2 plays a direct role in regulating VEGF signalling in endothelial cells (ECs). It modulates EC migration and differentiation through a process named endothelial-to-mesenchymal transition (EndMT), which plays a key role in angiogenesis. Upregulation of Dab2 gene is seen in circulating lymphocytes and monocytes of periodontitis patients. Hyperglycemic ECs exhibit downregulation of Dab2 mRNA and protein levels, along with reduced expression of genes involved in cellular metabolism, growth, and proliferation. Forkhead box protein M1 (FOXM1), belongs to the Forkhead family of transcriptional factors, is highly conserved & exerts regulatory control over Dab2 expression in endothelial cells during angiogenesis. Loss of FOXM1 is associated with upregulation of RANKL/OPG ratio. It also plays a crucial role in diabetes related cellular functions via beta cell proliferation, essential for pancreatic repair and insulin secretion. To the best of our knowledge the roles of VEGFR2, Dab2 and FOXM1 have not been investigated together in patients with periodontitis and diabetes. Hence, the aim of this study is to evaluate the salivary and serum levels of VEGFR2, Dab2 and FOXM1 in patients with generalized periodontitis and type 2 diabetes mellitus. |